Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001415889-16-005560
Filing Date
2016-04-19
Accepted
2016-04-19 06:48:12
Documents
6
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A mbvx10ka_dec312015.htm 10-K/A 676261
2 ex10-56.htm EX-10.56 96019
3 ex31-1.htm EX-31.1 18164
4 ex31-2.htm EX-31.2 18625
5 ex32-1.htm EX-32.1 7548
6 ex32-2.htm EX-32.2 7595
  Complete submission text file 0001415889-16-005560.txt   825346
Mailing Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121
Business Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001109196 (see all company filings)

EIN.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-31265 | Film No.: 161577959
SIC: 2834 Pharmaceutical Preparations